The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $77.27

Today's change-0.42 -0.54%
Updated August 18 4:01 PM EDT. Delayed by at least 15 minutes.
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $77.27

Today's change-0.42 -0.54%
Updated August 18 4:01 PM EDT. Delayed by at least 15 minutes.

Perrigo Company PLC down (U.S.)$0.42

Perrigo Company PLC closed lower Friday, dropping (U.S.)$0.42 or 0.54% to (U.S.)$77.27. Over the last five days, shares have lost 1.55% and are down 7.16% for the last year to date. This security has underperformed the S&P 500 by 25.81% during the last year.

Key company metrics

  • Open(U.S.) $77.59
  • Previous close(U.S.) $77.69
  • High(U.S.) $78.76
  • Low(U.S.) $77.24
  • Bid / Ask-- / --
  • YTD % change-7.16%
  • Volume1,446,753
  • Average volume (10-day)2,769,490
  • Average volume (1-month)1,674,301
  • Average volume (3-month)1,751,883
  • 52-week range(U.S.) $63.68 to (U.S.) $99.14
  • Beta0.67
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward16.87×
  • Forward PEG2.35×
  • Indicated annual dividend(U.S.) $0.64
  • Dividend yield0.83%
  • Trailing EPS(U.S.) -$20.55
Updated August 18 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-58.66%

Perrigo Company PLC has a net profit margin of -58.66%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.54%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 01, 201707/01/2017Apr 01, 201704/01/2017Dec 31, 201612/31/2016Oct 01, 201610/01/2016
Revenue1,2381,1941,3311,262
Total other revenue--------
Total revenue1,2381,1941,3311,262
Gross profit505464488485
Total cost of revenue733730844777
Total operating expense1,2241,0661,8162,731
Selling / general / administrative275282316282
Research & development43404250
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)175516151,622
Other operating expenses, total-2-36----
Operating income14129-485-1,469
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-7696-1,644-1,902
Income after tax-7072-1,359-1,590
Income tax, total-724-285-312
Net income-7072-1,359-1,590
Total adjustments to net income--------
Net income before extra. items-7072-1,359-1,590
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-7072-1,359-1,590
Inc. avail. to common incl. extra. items-7072-1,359-1,590
Diluted net income-7072-1,359-1,590
Dilution adjustment00----
Diluted weighted average shares143144144143
Diluted EPS excluding extraordinary itemsvalue per share-0.490.50-9.46-11.10
Dividends per sharevalue per share0.160.160.150.15
Diluted normalized EPSvalue per share0.310.76-6.68-3.74